Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review. (Q39144570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Jon A Kobashigawa

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

V Ruan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

L S C Czer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

M Kittleson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J Patel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

F Arabia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

F Esmailian

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

D Ramzy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

J Chung

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

M De Robertis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

A Trento

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

1 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

253-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure.

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Immunosuppressive strategies in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Drug Therapy in the Heart Transplant Recipient: Part I: Cardiac Rejection and Immunosuppressive Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction Therapy In Heart Transplantation: Is There A Role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Report from a consensus conference on the sensitized patient awaiting heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Assessment of batch to batch variation in polyclonal antithymocyte globulin preparations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Daclizumab to prevent rejection after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction immunosuppression with basiliximab in heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Renal insufficiency after heart transplantation: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction therapy in heart transplantation: where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Allograft vasculopathy versus atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Low incidence of graft arteriosclerosis after cardiac transplantation - risk factor analysis for patients with induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Detection and imaging of cardiac allograft vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

The nature of ischemia/reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Cardiac allograft vasculopathy: recent developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Endothelial loss and regeneration in a model of transplant arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

A novel mechanism of anti-T-lymphocyte globulin mediated by fractalkine in renal ischemia-reperfusion injury in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Anti-thymocyte gamma-globulin may prevent antibody production after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

The role of Thymoglobulin induction in kidney transplantation: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Spectrum of cancer risk among US solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Infection and malignancy after pediatric heart transplantation: the role of induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Lymphomas after solid organ transplantation: a collaborative transplant study report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

Incidence and prognosis of cancer following heart transplantation using RATG induction therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.11.034

10.1016/J.TRANSPROCEED.2016.11.034

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28219580%20AND%20SRC:MED&resulttype=core&format=json

release_kctgnwv3lngz7mnsurk3ypf7tu

3 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kctgnwv3lngz7mnsurk3ypf7tu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference